IVA News and Press, Inventiva S.A. From 05/16/22

Inventiva press release (NASDAQ:IVA): Cash position at €80.5m as of March 31, 2022 The Group did not generate any revenue in Q1 2022 Signature of a €50 million bullet credit facility agreement with the European Investment Bank For further details see: Inventiva r...

This article focuses on the major influences towards a biotech company's share price, rather than their value or opportunity. These catalysts will be important to consider when timing your entry and exit points. This article will be the last that focuses on evaluating individual h...

Inventiva S.A. (IVA) Q4 2021 Earnings Conference Call March 08, 2022 08:00 AM ET Company Participants Frédéric Cren - Chairman, Chief Executive Officer & Co-Founder Pierre Broqua - Chief Scientific Officer & Co-Founder Michael Cooreman - Chief Medical Officer Jean Volatier -...

Inventiva (NASDAQ:IVA) said the U.S. Food and Drug Administration (FDA) concluded that a phase 2 trial of the company's drug lanifibranor in combination empagliflozin to treat patients with non-cirrhotic NASH and Type 2 Diabetes (T2D) may proceed. The decision was made by the FDA after t...

Inventiva press release (NASDAQ:IVA): Q4 GAAP EPS of -€1.27. Revenue of €4.2M (+950.0% Y/Y). For further details see: Inventiva GAAP EPS of -€1.27, revenue of €4.2M

Inventiva (NASDAQ:IVA): 9M Revenue of €0.2M Cash and cash equivalents of €105.7M. Press Release For further details see: Inventiva reports Q3 results

Inventiva S.A. (IVA) Q2 2021 Results Conference Call September 21, 2021 08:00 AM ET Company Participants Frédéric Cren - Chairman, CEO and Co-Founder Pierre Broqua - CSO and Co-Founder Michael Cooreman - CMO Jean Volatier - CFO Conference Call Participants Lucy Codrington - Jefferie...

The following slide deck was published by Inventiva S.A. in conjunction with this event. For further details see: Inventiva (IVA) Investor Presentation - Slideshow

Gainers: Aptose Biosciences (APTO) +65%, Brainstorm Cell Therapeutics (BCLI) +13%, Prothena (PRTA) +12%, Armata Pharmaceuticals (ARMP) +8%, Inventiva (IVA) +8%.Losers: Benitec Biopharma (BNTC) -24%, Second Sight Medical Products (EYES) -1...

Inventiva S.A. (IVEVF) Q4 2020 Earnings Conference Call March 5, 2021 08:00 ET Company Participants Frédéric Cren - Chairman, Chief Executive Officer and Co-Founder Pierre Broqua - Chief Scientific Officer and Co-Founder Michael Cooreman - Chief Medical Officer Jean Volatier - Chief...